In vitro and in vivo antibacterial activities of KRM-1648 and KRM-1657, new rifamycin derivatives.

The in vitro and in vivo antibacterial activities of the new rifamycin derivatives KRM-1648 and KRM-1657 were compared with those of rifampin. Rifabutin, ciprofloxacin, and clarithromycin were also tested for reference. The respective MICs of KRM-1648 and KRM-1657 for 90% of the strains tested (MIC9...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Antimicrob Agents Chemother
Hauptverfasser:	Fujii, K, Tsuji, A, Miyazaki, S, Yamaguchi, K, Goto, S
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Microbiology (ASM) 1994
Schlagworte:	Research Article
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC188160/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8067748/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.5.1118
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!